Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Operating Activities
Net loss	$ (16,201)	$ (16,612)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	27,023	25,671
Amortization of deferred financing costs	1,753	1,008
Credit loss expense (reversal), net	7,341	(1,567)
Write-downs	5,432	462
Deferred income tax (benefit) expense	(300)	33
Share-based and other non-cash compensation	13,966	12,332
Unrealized foreign currency exchange loss (gain)	841	(490)
Realized and unrealized investment gains	(64)	(5,281)
Changes in assets and liabilities:
Accounts receivable	(14,745)	(11,049)
Inventories	(6,949)	1,867
Film assets	(10,420)	(5,808)
Deferred revenue	(5,291)	(447)
Changes in other operating assets and liabilities	(7,679)	(17,135)
Net cash used in operating activities	(5,293)	(17,016)
Investing Activities
Purchase of property, plant and equipment	(2,934)	(1,365)
Investment in equipment for joint revenue sharing arrangements	(8,651)	(2,397)
interest in film classified as a financial instrument	(4,731)
Acquisition of other intangible assets	(1,680)	(2,631)
Proceeds from sale of equity securities		17,769
Net cash (used in) provided by investing activities	(17,996)	11,376
Financing Activities
Proceeds from issuance of convertible notes, net		223,675
Debt issuance costs related to convertible notes		(242)
Purchase of capped calls related to convertible notes		(19,067)
Revolving credit facility borrowings		3,600
Repayments of revolving credit facility borrowings		(300,243)
Credit facility amendment fees paid	(2,028)	(32)
Taxes withheld and paid on employee stock awards vested	(3,393)	(3,045)
Common shares issued - stock options exercised		883
Principal payment under finance lease obligations	(890)
Dividends paid to non-controlling interests		(2,099)
Net cash used in financing activities	(57,510)	(96,570)
Effects of exchange rate changes on cash and cash equivalents	1,200	(1,044)
Decrease in cash and cash equivalents during period	(79,599)	(103,254)
Cash and cash equivalents, beginning of period	189,711	317,379
Cash and cash equivalents, end of period	110,112	$ 214,125
IMAX Corporation
Financing Activities
Repurchase of common shares	(49,355)
IMAX China
Financing Activities
Repurchase of common shares	$ (1,844)